AU2005254616A1 - Analysis of methylated nucleic acid - Google Patents

Analysis of methylated nucleic acid Download PDF

Info

Publication number
AU2005254616A1
AU2005254616A1 AU2005254616A AU2005254616A AU2005254616A1 AU 2005254616 A1 AU2005254616 A1 AU 2005254616A1 AU 2005254616 A AU2005254616 A AU 2005254616A AU 2005254616 A AU2005254616 A AU 2005254616A AU 2005254616 A1 AU2005254616 A1 AU 2005254616A1
Authority
AU
Australia
Prior art keywords
nucleic acid
methylated
sample
acid fragments
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005254616A
Other languages
English (en)
Inventor
Dirk Schuebeler
Michael Philippe Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Original Assignee
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research filed Critical Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Publication of AU2005254616A1 publication Critical patent/AU2005254616A1/en
Priority to AU2009202745A priority Critical patent/AU2009202745A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2005254616A 2004-06-18 2005-03-03 Analysis of methylated nucleic acid Abandoned AU2005254616A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2009202745A AU2009202745A1 (en) 2004-06-18 2009-07-07 Analysis of methylated nucleic acid

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0413688.3A GB0413688D0 (en) 2004-06-18 2004-06-18 Analysis of methylated nucleic acid
GB0413688.3 2004-06-18
PCT/EP2005/002251 WO2005123942A2 (en) 2004-06-18 2005-03-03 Analysis of methylated nucleic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2009202745A Division AU2009202745A1 (en) 2004-06-18 2009-07-07 Analysis of methylated nucleic acid

Publications (1)

Publication Number Publication Date
AU2005254616A1 true AU2005254616A1 (en) 2005-12-29

Family

ID=32750180

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2005254616A Abandoned AU2005254616A1 (en) 2004-06-18 2005-03-03 Analysis of methylated nucleic acid
AU2009202745A Ceased AU2009202745A1 (en) 2004-06-18 2009-07-07 Analysis of methylated nucleic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2009202745A Ceased AU2009202745A1 (en) 2004-06-18 2009-07-07 Analysis of methylated nucleic acid

Country Status (8)

Country Link
US (2) US20090270482A1 (enExample)
EP (1) EP1761639B1 (enExample)
JP (1) JP2008502332A (enExample)
AU (2) AU2005254616A1 (enExample)
CA (1) CA2568575A1 (enExample)
ES (1) ES2401110T3 (enExample)
GB (1) GB0413688D0 (enExample)
WO (1) WO2005123942A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005034628B4 (de) * 2005-07-19 2007-08-23 Epigenomics Ag Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA
EP1862555A1 (en) * 2006-05-29 2007-12-05 Klinikum der Universität Regensburg Means and methods for diagnosing cancer or a corresponding predisposition
EP2050828A3 (en) * 2006-06-12 2009-08-26 Oncomethylome Sciences S.A. Methylation markers for early detection and prognosis of colon cancers
CN110079598A (zh) * 2007-10-23 2019-08-02 临床基因组学有限公司 诊断新生物的方法–ii
JP2009247260A (ja) * 2008-04-04 2009-10-29 Sumitomo Chemical Co Ltd Ｄｎａメチル化測定方法
WO2010118559A1 (zh) * 2009-04-17 2010-10-21 Lai Hung-Cheng 一种癌症筛检的方法
PL2529032T3 (pl) 2010-01-26 2017-07-31 Nipd Genetics Ltd Sposoby i kompozycje do nieinwazyjnego prenatalnego diagnozowania aneuploidii płodu
US8278049B2 (en) 2010-04-26 2012-10-02 Ann & Robert H. Lurie Children's Hospital of Chicago Selective enrichment of CpG islands
US20120004132A1 (en) * 2010-07-02 2012-01-05 Affymetrix, Inc. Detection of Nucleic Acids and Proteins
JP5916058B2 (ja) * 2011-08-26 2016-05-11 国立大学法人東北大学 細胞ストレス状態のバイオマーカー
WO2013123481A1 (en) 2012-02-16 2013-08-22 Cornell University Methods and kit for characterizing the modified base status of a transcriptome
JP6451634B2 (ja) * 2013-08-21 2019-01-16 富士レビオ株式会社 吸収剤ポリヌクレオチドを用いた修飾核酸塩基の測定方法およびそのキット
EP3298166B1 (en) 2015-05-22 2020-02-12 Nipd Genetics Public Company Limited Multiplexed parallel analysis of targeted genomic regions for non-invasive prenatal testing
KR101735415B1 (ko) * 2015-07-31 2017-05-16 한국과학기술연구원 헥산알 노출 특이적 메틸화 마커 유전자 및 이를 이용한 확인 방법
WO2017130839A1 (ja) * 2016-01-27 2017-08-03 住友化学株式会社 センサーチップ及びセンシングシステム
JP7441003B2 (ja) * 2016-02-23 2024-02-29 ダブテイル ゲノミクス エルエルシー ゲノムアセンブリのためのフェージングされたリードセットの生成とハプロタイプフェージング
EP3606550A2 (en) 2017-04-03 2020-02-12 Neon Therapeutics, Inc. Protein antigens and uses thereof
US11793867B2 (en) 2017-12-18 2023-10-24 Biontech Us Inc. Neoantigens and uses thereof
US12246067B2 (en) 2018-06-19 2025-03-11 Biontech Us Inc. Neoantigens and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654183A (en) * 1992-07-27 1997-08-05 California Institute Of Technology Genetically engineered mammalian neural crest stem cells
US5518901A (en) * 1993-04-19 1996-05-21 Murtagh; James J. Methods for adapting nucleic acid for detection, sequencing, and cloning using exonuclease
US5714325A (en) * 1993-09-24 1998-02-03 New England Medical Center Hospitals Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
US5866323A (en) * 1995-04-07 1999-02-02 Case Western Reserve University Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors
AU7829398A (en) * 1997-06-09 1998-12-30 University Of Southern California A cancer diagnostic method based upon dna methylation differences
US6337392B1 (en) * 1998-05-07 2002-01-08 The Rockefeller University Lens transcriptional control elements and methods of use thereof
US6994971B1 (en) * 1999-10-08 2006-02-07 University Of Utah Research Foundation Particle analysis assay for biomolecular quantification
JP2003514031A (ja) * 1999-11-19 2003-04-15 トーマス ブイ． ティットル， Ｔｒ３特異的結合剤およびその使用のための方法
WO2002000842A2 (en) * 2000-06-23 2002-01-03 The University Of Chicago Methods for isolating centromere dna
US20030157481A1 (en) * 2001-12-10 2003-08-21 Benjamin Thomas L. Diagnosing and treating cancer cells using T-HR mutants and their targets
AU2002318336A1 (en) * 2001-06-08 2002-12-23 U.S. Genomics, Inc. Methods and products for analyzing nucleic acids based on methylation status
AU2003206443A1 (en) * 2002-02-20 2003-09-09 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis
DE50207801D1 (de) * 2002-09-18 2006-09-21 Sirs Lab Gmbh Verfahren zum Nachweis prokaryontischer DNA
AU2003900368A0 (en) * 2003-01-24 2003-02-13 Human Genetic Signatures Pty Ltd Assay for nucleic acid molecules
JP3854943B2 (ja) * 2003-05-23 2006-12-06 独立行政法人科学技術振興機構 Ｄｎａメチル化率の測定方法
EP1524523A1 (en) * 2003-10-17 2005-04-20 Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts Use of ADAM 12 for diagnosis and therapy of preeclampsia
JP4688792B2 (ja) * 2004-02-20 2011-05-25 独立行政法人科学技術振興機構 Ｄｎａメチル化分析用ｄｎａアレイ及びその製造方法並びにｄｎａメチル化分析方法

Also Published As

Publication number Publication date
AU2009202745A1 (en) 2009-07-30
WO2005123942A2 (en) 2005-12-29
JP2008502332A (ja) 2008-01-31
CA2568575A1 (en) 2005-12-29
WO2005123942A3 (en) 2006-04-13
ES2401110T3 (es) 2013-04-17
US20090270482A1 (en) 2009-10-29
GB0413688D0 (en) 2004-07-21
US20120288509A1 (en) 2012-11-15
EP1761639A2 (en) 2007-03-14
EP1761639B1 (en) 2013-01-02

Similar Documents

Publication Publication Date Title
US20120288509A1 (en) Analysis of methylated nucleic acid
CN107586835B (zh) 一种基于单链接头的下一代测序文库的构建方法及其应用
AU2017257225B2 (en) Allele editing and applications thereof
De Bruin et al. Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression
US20190389969A1 (en) Ntrk2 fusions
Chen et al. The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin
US10370725B2 (en) FGR fusions
EP3132054B1 (en) Met fusions
US10246750B2 (en) Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion
JP4527280B2 (ja) 示差スクリーニング
US6413723B1 (en) Methods and compositions for identifying nucleic acids containing cis acting elements
AU2017200138A1 (en) Compositions and methods of nucleic acid-targeting nucleic acids
WO2018132369A1 (en) Biomarkers predictive of anti-immune checkpoint response
WO2001066719A1 (fr) Nouveau gene clone en neuroblastome humain et nouveaux fragments de gene
JP2007502129A (ja) 短鎖干渉ｒｎａライブラリーならびに合成および使用の方法
Keuthan et al. Alternative RNA splicing in the retina: insights and perspectives
JP2024019511A (ja) がんにおける融合遺伝子
Sun et al. CRIPTO3, a presumed pseudogene, is expressed in cancer
AU2011203953B2 (en) Analysis of methylated nucleic acid
Sankhe et al. Fusion oncogenes in rhabdomyosarcoma: model systems, mechanisms of tumorigenesis, and therapeutic implications
US20040076978A1 (en) Method to identify genes associated with chronic myelogenous leukemia
US20030059788A1 (en) Genetic markers of toxicity, preparation and uses thereof
Huang et al. CTCF mediates dosage and sequence-context-dependent transcriptional insulation through formation of local chromatin domains
JP2006504426A (ja) Ｒｎａスプライス部位の検出のための定性的差異スクリーニング
US7932030B2 (en) System for pulling out regulatory elements using yeast

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted